<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02336802</url>
  </required_header>
  <id_info>
    <org_study_id>bramvervliet</org_study_id>
    <nct_id>NCT02336802</nct_id>
  </id_info>
  <brief_title>Threat-Avoidance Learning in Anxiety Patients</brief_title>
  <acronym>AVOID</acronym>
  <official_title>The Experimental Study of Threat-Avoidance in Anxiety Patients: Behavioral, Emotional, and Neural Correlates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anxiety disorders are characterized by exaggerated levels of fear that are not proportional
      to the actual level of threat. More specifically, anxiety patients have marked deficits in
      the downregulation of fear reactions during situations of objective safety. Pre-clinical
      research on Pavlovian fear conditioning and extinction has discovered that fear
      downregulation stems from areas in the prefrontal cortex (the ventro-medial prefrontal
      cortex, vmPFC) that recruit intercalated cells in the amygdala to inhibit its central
      nucleus, which is responsible for a variety of behavioral expressions of fear (Milad &amp; Quirk,
      2012). Accordingly, functional magnetic resonance imaging studies (fMRI) revealed reduced
      vmPFC activity coupled with increased fear reactions during situations of objective safety in
      anxiety patients (Milad et al., 2009). Another core symptom of anxiety disorders, though much
      less investigated, is the excessive avoidance of situations that trigger the fears. These
      'safety behaviors' often interfere with daily life activities and valued goals in life, and
      they are thought to perpetuate the exaggerated levels of fear by precluding opportunities to
      learn that the feared situations are actually not dangerous. Surprisingly, experimental
      research on avoidance behaviors in anxiety patients is virtually non-existent. This
      experiment modifies the Pavlovian fear conditioning procedure to include avoidance, and
      explores the behavioral and neural processes of this type of fear regulation in anxiety
      patients (trans-diagnostically) and healthy individuals.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>functional magnetic resonance imaging</measure>
    <time_frame>1.5 hours</time_frame>
    <description>We will measure functional MRI during fear conditioning, avoidance and generalization. Furthermore, we will measure changes in structural MRI data, Diffusion Tensor Imaging (DTI) data and resting state fMRI data.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin conductance reactivity</measure>
    <time_frame>1.5 hours</time_frame>
    <description>fluctuations in skin conductance will be measured alongside MRI data collection, as a peripheral physiological measure of fear.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaires</measure>
    <time_frame>2 hours</time_frame>
    <description>In a separate sessions, participants will fill out a variety of personality questionnaires probing levels of anxiety and avoidance tendency.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Panic Disorder</condition>
  <condition>Phobic Disorders</condition>
  <condition>Stress Disorders, Traumatic</condition>
  <arm_group>
    <arm_group_label>Healthy Control Group</arm_group_label>
    <description>Volunteers that meet no diagnostic criteria for mental disorders.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Panic Disorder Group</arm_group_label>
    <description>Volunteers that meet diagnostic criteria for Panic Disorder.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phobic Disorder Group</arm_group_label>
    <description>Volunteers that meet diagnostic criteria for a Phobic Disorder.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PTSD group</arm_group_label>
    <description>Volunteers that meet diagnostic criteria for Post-Traumatic Stress Disorder</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Avoidance experiment</intervention_name>
    <description>Participants complete an avoidance task</description>
    <arm_group_label>Healthy Control Group</arm_group_label>
    <arm_group_label>Panic Disorder Group</arm_group_label>
    <arm_group_label>Phobic Disorder Group</arm_group_label>
    <arm_group_label>PTSD group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy Controls, Panic Disorder, Phobic Disorders, Post-Traumatic Stress Disorder
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 years of age. Proficient in English. Right-handed Free of medication that affect
             cerebral metabolism. Able to give informed consent. High stress level (defined as a
             score of &gt;= 3 on the 4-item Perceived Stress Scale).

        Exclusion Criteria:

        History of neurologic or psychiatric disease (other than the specified anxiety disorder),
        substance abuse or dependence that is current or within the last year.

        Major/chronic medical conditions. History of head injury resulting in prolonged loss of
        consciousness and/or neurological sequelae. History of seizures. History of stroke Prior
        neurosurgical procedure. Metal in the body, metal injury to the eyes. Implanted pacemaker,
        medication pump, vagal stimulator, deep brain stimulator, TENS unit, or
        ventriculo-peritoneal shunt. Pregnancy; breastfeeding or nursing Claustrophobia Weight &gt;
        350 lbs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirk Hermans, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of KU Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bram Vervliet, Ph.D.</last_name>
    <phone>+32 16 32 61 17</phone>
    <email>bram.vervliet@ppw.kuleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of KU Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bram Vervliet, Ph.D.</last_name>
      <phone>+32 16 32 61 17</phone>
      <email>bram.vervliet@ppw.kuleuven.be</email>
    </contact>
    <investigator>
      <last_name>Bram Vervliet, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dirk Hermans, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Milad MR, Pitman RK, Ellis CB, Gold AL, Shin LM, Lasko NB, Zeidan MA, Handwerger K, Orr SP, Rauch SL. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry. 2009 Dec 15;66(12):1075-82. doi: 10.1016/j.biopsych.2009.06.026. Epub 2009 Sep 12.</citation>
    <PMID>19748076</PMID>
  </reference>
  <reference>
    <citation>Milad MR, Quirk GJ. Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol. 2012;63:129-51. doi: 10.1146/annurev.psych.121208.131631. Review.</citation>
    <PMID>22129456</PMID>
  </reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2015</study_first_submitted>
  <study_first_submitted_qc>January 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2015</study_first_posted>
  <last_update_submitted>February 5, 2015</last_update_submitted>
  <last_update_submitted_qc>February 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Bram Vervliet</investigator_full_name>
    <investigator_title>Ph.D.</investigator_title>
  </responsible_party>
  <keyword>Anxiety</keyword>
  <keyword>Fear</keyword>
  <keyword>Avoidance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Panic Disorder</mesh_term>
    <mesh_term>Phobic Disorders</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

